Search Results
Found 6,153 results for "cps products"
Safety Alert
Health Canada
For Health Professionals - Voluntary Type 1 Recall of ratio-Valproic (valproic acid) 500-mg Enteric-Coated Capsules in Canada
Marketed health products
Health CanadaGeneral Alert
For Health Professionals - Voluntary Type 1 Recall of ratio-Valproic (valproic acid) 500-mg Enteric-Coated Capsules in Canada
May 17, 2007Marketed health products
Safety Alert
Health Canada
For Health Professionals - Voluntary Type 1 Recall of Depakene (valproic acid) 500-mg Enteric-Coated Capsules in Canada
Marketed health products
Health CanadaGeneral Alert
For Health Professionals - Voluntary Type 1 Recall of Depakene (valproic acid) 500-mg Enteric-Coated Capsules in Canada
May 16, 2007Marketed health products
Safety Alert
Health Canada
Archived - For the Public - Important Safety Information on IRESSA (gefitinib) - AstraZeneca Canada Inc.
Marketed health products
Health CanadaGeneral Alert
Archived - For the Public - Important Safety Information on IRESSA (gefitinib) - AstraZeneca Canada Inc.
May 14, 2007Marketed health products
Safety Alert
Health Canada
For Health Professionals - Urgent Medical Device Information - Subset of Implantable Cardiac Defibrillators and Cardiac Resynchronization Therapy Defibrillators
Marketed health products
Health CanadaGeneral Alert
For Health Professionals - Urgent Medical Device Information - Subset of Implantable Cardiac Defibrillators and Cardiac Resynchronization Therapy Defibrillators
May 9, 2007Marketed health products
Safety Alert
Health Canada
For Health Professionals - Association between Long-Term Treatment with Actos (pioglitazone hydrochloride) Tablets for Type 2 Diabetes Mellitus and Fractures in Women
Marketed health products
Health CanadaGeneral Alert
For Health Professionals - Association between Long-Term Treatment with Actos (pioglitazone hydrochloride) Tablets for Type 2 Diabetes Mellitus and Fractures in Women
May 7, 2007Marketed health products
Safety Alert
Health Canada
Archived - Association between Long-Term Treatment with ACTOS (pioglitazone hydrochloride) Tablets for Type 2 Diabetes Mellitus and Fractures in Women
Marketed health products
Health CanadaGeneral Alert
Archived - Association between Long-Term Treatment with ACTOS (pioglitazone hydrochloride) Tablets for Type 2 Diabetes Mellitus and Fractures in Women
May 7, 2007Marketed health products
Safety Alert
CPSC
Coast Spas and Franklin Electric Co. Recall Coast Spas Due to Fire Hazard
Coast Spas Manufacturing Inc., of Langley, British Columbia, Canada (spas), The Engineered Motor Products Division of Franklin Electric Company Inc., of Bluffton, Ind. (motors)

CPSCGeneral Alert
Coast Spas and Franklin Electric Co. Recall Coast Spas Due to Fire Hazard
The recalled spas have a circulating pump and motor assembly, which can overheat and pose a fire hazard.
May 3, 2007Coast Spas Manufacturing Inc., of Langley, British Columbia, Canada (spas), The Engineered Motor Products Division of Franklin Electric Company Inc., of Bluffton, Ind. (motors)
Safety Alert
CPSC
Graco Children's Products Recalls to Replace Soft Blocks Towers on Activity Centers Due to Choking Hazard
Graco Children's Products Inc., of Exton, Pa.

CPSCGeneral Alert
Graco Children's Products Recalls to Replace Soft Blocks Towers on Activity Centers Due to Choking Hazard
The plastic covering on the soft block towers can detach, posing a choking hazard to infants.
May 2, 2007Graco Children's Products Inc., of Exton, Pa.
Safety Alert
Health Canada
Archived - For Health Professionals - Important safety information and new prescribing information for the erythropoiesis-stimulating agents (ESAs), Aranesp (darbepoietin alfa) and Eprex (epoetin alfa)
Marketed health products
Health CanadaGeneral Alert
Archived - For Health Professionals - Important safety information and new prescribing information for the erythropoiesis-stimulating agents (ESAs), Aranesp (darbepoietin alfa) and Eprex (epoetin alfa)
Apr 20, 2007Marketed health products
Safety Alert
Health Canada
Archived - For the Public - Important safety information and new prescribing information for the erythropoiesis-stimulating agents (ESAs), Aranesp (darbepoietin alfa) and EPREX (epoetin alfa)
Marketed health products
Health CanadaGeneral Alert
Archived - For the Public - Important safety information and new prescribing information for the erythropoiesis-stimulating agents (ESAs), Aranesp (darbepoietin alfa) and EPREX (epoetin alfa)
Apr 20, 2007Marketed health products
Safety Alert
Health Canada
For Health Professionals - Urgent Medical Device Safety Information and Corrective Action - DDU-100 Series Automatic External Defibrillators
Marketed health products
Health CanadaGeneral Alert
For Health Professionals - Urgent Medical Device Safety Information and Corrective Action - DDU-100 Series Automatic External Defibrillators
Apr 12, 2007Marketed health products
Safety Alert
Health Canada
Archived - For the Public - Urgent Medical Device Safety Information and Corrective Action - DDU-100 Series Automatic External Defibrillators
Marketed health products
Health CanadaGeneral Alert
Archived - For the Public - Urgent Medical Device Safety Information and Corrective Action - DDU-100 Series Automatic External Defibrillators
Apr 12, 2007Marketed health products
Safety Alert
Health Canada
For Health Professionals - Voluntary suspension of sales of Zelnorm due to cardiovascular ischemic events
Marketed health products
Health CanadaGeneral Alert
For Health Professionals - Voluntary suspension of sales of Zelnorm due to cardiovascular ischemic events
Apr 2, 2007Marketed health products
Safety Alert
Health Canada
Archived - For the Public - Voluntary suspension of sales of Zelnorm due to cardiovascular ischemic events - Novartis Pharmaceuticals Canada Inc.
Marketed health products
Health CanadaGeneral Alert
Archived - For the Public - Voluntary suspension of sales of Zelnorm due to cardiovascular ischemic events - Novartis Pharmaceuticals Canada Inc.
Apr 2, 2007Marketed health products
Safety Alert
Health Canada
Archived - For the Public - Association of Trasylol (aprotinin) with hypersensitivity reactions and renal dysfunction - Bayer Inc.
Marketed health products
Health CanadaGeneral Alert
Archived - For the Public - Association of Trasylol (aprotinin) with hypersensitivity reactions and renal dysfunction - Bayer Inc.
Mar 30, 2007Marketed health products
Safety Alert
Health Canada
Notice to Hospitals - Association of Trasylol (aprotinin) with hypersensitivity reactions and renal dysfunction
Marketed health products
Health CanadaGeneral Alert
Notice to Hospitals - Association of Trasylol (aprotinin) with hypersensitivity reactions and renal dysfunction
Mar 30, 2007Marketed health products
Safety Alert
CPSC
Regent Products Corp. Recalls Stuffed Ball Toys Due to Lead Hazard
Regent Products Corp., River Grove, IL

CPSCGeneral Alert
Regent Products Corp. Recalls Stuffed Ball Toys Due to Lead Hazard
The stuffed balls contain lead paint, which is toxic if ingested by young children and can cause adverse health effects.
Mar 28, 2007Regent Products Corp., River Grove, IL
Safety Alert
Health Canada
Archived - For the Public - Association of acute renal failure (severe kidney problems) and reports of cytopenias (low blood cell counts) with EXJADE (deferasirox)
Marketed health products
Health CanadaGeneral Alert
Archived - For the Public - Association of acute renal failure (severe kidney problems) and reports of cytopenias (low blood cell counts) with EXJADE (deferasirox)
Mar 19, 2007Marketed health products
Safety Alert
Health Canada
For Health Professionals - Association of acute renal failure (severe kidney problems) and reports of cytopenias (low blood cell counts) with Exjade (deferasirox)
Marketed health products
Health CanadaGeneral Alert
For Health Professionals - Association of acute renal failure (severe kidney problems) and reports of cytopenias (low blood cell counts) with Exjade (deferasirox)
Mar 19, 2007Marketed health products
Safety Alert
Health Canada
Notice to Hospitals - Important Safety Information on the Use of Waist and Torso Patient Restraints
Marketed health products
Health CanadaGeneral Alert
Notice to Hospitals - Important Safety Information on the Use of Waist and Torso Patient Restraints
Mar 19, 2007Marketed health products
Safety Alert
Health Canada
For Health Professionals - Association of Omniscan (Gadodiamide) and Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy (NSF/NFD)
Marketed health products
Health CanadaGeneral Alert
For Health Professionals - Association of Omniscan (Gadodiamide) and Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy (NSF/NFD)
Mar 13, 2007Marketed health products
Safety Alert
Health Canada
Notice to Hospitals - Association of gadolinium-containing contrast agents and Nephrogenic Systemic Fibrosis /Nephrogenic Fibrosing Dermopathy (NSF/NFD)
Marketed health products
Health CanadaGeneral Alert
Notice to Hospitals - Association of gadolinium-containing contrast agents and Nephrogenic Systemic Fibrosis /Nephrogenic Fibrosing Dermopathy (NSF/NFD)
Mar 13, 2007Marketed health products
Safety Alert
Health Canada
Archived - For the Public - Association of Omniscan™ (Gadodiamide) and Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy (NSF/NFD) - GE Healthcare Canada
Marketed health products
Health CanadaGeneral Alert
Archived - For the Public - Association of Omniscan™ (Gadodiamide) and Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy (NSF/NFD) - GE Healthcare Canada
Mar 13, 2007Marketed health products
Safety Alert
Health Canada
For Health Professionals - Important information concerning unpredictable events in medical equipment due to Daylight Savings Time change
Marketed health products
Health CanadaGeneral Alert
For Health Professionals - Important information concerning unpredictable events in medical equipment due to Daylight Savings Time change
Mar 7, 2007Marketed health products